Pfizer (Vietnam) Limited Company and Vietnam Vaccine Joint Stock Company (VNVC) on Wednesday (May 24) signed a memorandum of understanding (MoU) to partner on protecting public health by increasing the rate of proactive prevention of dangerous infections in the period of 2023-25.
Facilities of Tam Anh General Hospital in both Hanoi and Ho Chi Minh City on March 24 received the first batch of Evusheld, a drug developed by AstraZeneca to fight COVID-19 infection by combining two long-acting monoclonal antibodies.